(Total Views: 955)
Posted On: 08/12/2020 1:14:22 AM
Post# of 153815
I sent the following to Cytodyn this evening:
Dr. Pourhassan, et. al.
First, congratulations on the successful M/M Ph. 2 results.
Strong suggestion: Please have someone from Cytodyn pre-screen the callers' questions and then read them on-air rather than let the caller read them him/herself. To be blunt, IMHO the last listener Q & A was an embarrassing waste of everyone's time despite Dr. Pourhassan's valiant attempts to keep it on track. Too many of the callers weren't brief and to the point and a lot of the questions were either asked by someone who had very little knowledge of Leronlimab or were completely off topic and/or inappropriate.
In any case, good luck with the call and in your coming dealings with the FDA.
Sincerely, Ganesha Shareholder
Dr. Pourhassan, et. al.
First, congratulations on the successful M/M Ph. 2 results.
Strong suggestion: Please have someone from Cytodyn pre-screen the callers' questions and then read them on-air rather than let the caller read them him/herself. To be blunt, IMHO the last listener Q & A was an embarrassing waste of everyone's time despite Dr. Pourhassan's valiant attempts to keep it on track. Too many of the callers weren't brief and to the point and a lot of the questions were either asked by someone who had very little knowledge of Leronlimab or were completely off topic and/or inappropriate.
In any case, good luck with the call and in your coming dealings with the FDA.
Sincerely, Ganesha Shareholder
(10)
(0)
